Skip to main content

Hedlund Laboratory

Associate Professor

Eva Hedlund

Phone: +46-(0)8-524 878 84
E-mail: eva.hedlund@ki.se

Research focus

Neurodegenerative diseases are characterized by the selective loss of specific neuronal populations with corresponding distinct clinical features, even when the pathogenic proteins are ubiquitously expressed. The lethal motor neuron diseases (MNDs) amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA) are defined by the loss of somatic motor neurons that innervate muscles in arms, legs, trunk and face, leading to muscle wasting. However, not all motor neurons are equally vulnerable; certain groups of motor neurons are spared, including those in the oculomotor and trochlear nuclei, controlling eye movement and motor neurons in the Onuf's nucleus, controlling pelvic muscles.

The reasons for the differential vulnerability to degeneration among motor neuron groups are unknown. The underlying causes of ALS and SMA appear quite distinct, but the similar pattern of motor neuron degeneration and sparing indicate that these diseases could share degenerative and protective pathways, independent of their distinct etiologies. Investigating cell intrinsic pathways that are differentially activated within resistant and vulnerable motor neurons could reveal mechanisms of selective neuronal degeneration and lead to therapies preventing progressive motor neuron loss.

Research in the Hedlund lab is aimed at elucidating mechanisms of neuronal vulnerability and resistance with the goal of identifying new molecular targets for the treatment of MNDs. Towards this goal, we utilize laser capture microdissection coupled with RNA sequencing to dissect molecular pathways in distinct motor neuron populations in animal models of MNDs. We also perform cross-disease analyses of degenerative and regenerative axonal responses at neuromuscular junctions - the specialized synapses between motor neurons and muscle. Motor neuron cultures derived from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) harboring disease-inducing mutations are coupled with microfluidics to model MNDs and study neuronal vulnerability and protection in vitro. Finally, we modulate candidate gene expression in vivo in transgenic MND mouse models to induce motor neuron protection and axonal regeneration.

Neuromuscular junctions in the caudal band of the levator auris longus (LAL) muscle of a P5 wild-type mouse (left) where the post-synaptic endplates are visualized using alpha-bungarotoxin (red) and the pre-synaptic terminals and axons are shown by neurofilament and SV2A staining (green). Mouse embryonic stem (ES) cell derived motor neurons (right) visualized by a Hb9eGFP reporter (green) and Islet (red) staining. Photographs by Laura Comley and Eva Hedlund.

Selected publications

30540963

28754496

28409282

27387371

27180807

27246266

26502195

25697826

Group members

Julio Aguila BenitezPostdoc
Staffan CullheimProfessor, senior
Eva HedlundDocent, Senior researcher
Jacob JasperAssociated
Nigel KeeAssociated
Jik NijssenPhD student
Christoph SchweingruberPostdoc